Subacute infarct treatment represents a critical window in cerebrovascular medicine, where timely intervention can dramatically alter the trajectory of patient outcomes. This phase, typically defined as occurring between 24 hours and two weeks following the initial ischemic event, demands a nuanced approach that balances the risks of hemorrhagic transformation with the imperative to restore cerebral blood flow. Unlike the acute management window, which often hinges on ultra-early intervention, the subacute period requires a sophisticated understanding of evolving tissue penumbras and the complex interplay between infarction and surrounding oligemia.
Modern imaging modalities, particularly advanced MRI sequences like diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI), have revolutionized the identification of potentially salvageable tissue during the subacute phase. These tools allow clinicians to differentiate between core infarcts, which are irrevocably damaged, and the ischemic penumbra, which remains viable but at risk. Treatment strategies in this timeframe are increasingly guided by the presence of this penumbra, shifting the focus from rigid time windows to a more physiological assessment of brain tissue viability, thereby expanding the therapeutic possibilities for many patients who present beyond the hyperacute period.
Pharmacological and Interventional Strategies
The pharmacological landscape for subacute infarct treatment has evolved significantly, with a careful recalibration of antithrombotic therapy taking center stage. For patients not candidates for endovascular thrombectomy, the initiation or continuation of dual antiplatelet therapy (DAPT), typically aspirin plus clopidogrel, is a cornerstone of management, particularly in the context of minor strokes or high-risk transient ischemic attacks (TIAs). This aggressive antiplatelet strategy has been robustly supported by clinical trials, demonstrating a significant reduction in early recurrent stroke risk without a proportional increase in major hemorrhage when compared to monotherapy.
For those who have undergone successful endovascular mechanical thrombectomy, the subacute period is pivotal for addressing the underlying atherosclerotic pathology that precipitated the event. Stent placement in cervical or intracranial arteries may be considered in select cases of severe stenosis, and the subsequent management of these patients requires meticulous optimization of medical therapy. This often involves a delicate balance between potent antiplatelet regimens and vigilant monitoring for in-stent thrombosis or restenosis, ensuring that the newly restored vessel patency is maintained over the long term.
Endovascular Therapy's Expanding Role
While the landmark trials for endovascular therapy predominantly focused on patients within 6 to 24 hours of symptom onset, the definition of "time last known well" is becoming more nuanced, particularly in cases of wake-up strokes or those with unknown onset times. Advanced imaging selection criteria, such as the ASPECTS (Alberta Stroke Programme Early CT Score) and assessments of collateral circulation, are now being applied to extend the eligibility window for thrombectomy into the subacute horizon. This expansion underscores a paradigm shift toward treating based on tissue biology rather than solely on chronological time, offering hope to a broader patient demographic.
Procedural success in the subacute setting is intricately linked to the expertise of the interventionist and the integration of a multidisciplinary team. Neurologists, neurointerventional radiologists, and neurocritical care specialists must collaborate seamlessly to manage complications such as reperfusion injury, which can manifest as cerebral edema or symptomatic intracranial hemorrhage in the days following the intervention. Careful hemodynamic optimization and neuromonitoring are therefore essential components of the subacute treatment protocol, requiring a high level of vigilance and coordinated care.
Prognosis and Long-Term Management
The prognosis following a subacute infarct is heavily influenced by the initial infarct volume, the effectiveness of recanalization, and the presence of comorbidities. Patients who present with a large vessel occlusion and achieve successful thrombectomy generally demonstrate a more favorable functional outcome compared to those managed with medical therapy alone. However, the recovery trajectory is often protracted, necessitating a comprehensive rehabilitation plan that addresses not only motor and cognitive deficits but also emotional and psychological sequelae, such as post-stroke depression, which can significantly impact long-term adherence to secondary prevention strategies.
